Who owns AbbVie Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ABBV from SEC Form 13F filings across 4,224 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 4,224 institutions disclosed 1.33B shares of AbbVie Inc. worth $357.69B — about 75.4% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
4,224
13F holders
$357.69B
value, 2026 filers
75.4%
of shares outstanding (1.33B sh)
405
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ABBV's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 149.5M | $37.62B | 0.6% | 8.5% | -0.8% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 115.4M | $29.04B | 0.6% | 6.5% | +0.4% |
| 3 | STATE STREET CORP | 82.6M | $20.78B | 0.6% | 4.7% | +1.7% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 48.5M | $12.20B | 0.5% | 2.7% | -2.1% |
| 5 | JPMORGAN CHASE & CO | 47.9M | $12.17B | 0.7% | 2.7% | -15.6% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 47.0M | $11.81B | 0.6% | 2.7% | +0.6% |
| 7 | MORGAN STANLEY | 38.9M | $9.79B | 0.5% | 2.2% | +2.3% |
| 8 | Capital Research Global Investors | 30.1M | $7.57B | 1.1% | 1.7% | -3.7% |
| 9 | NORGES BANKNEW | 25.6M | $6.43B | 0.6% | 1.4% | new |
| 10 | BANK OF AMERICA CORP /DE/ | 21.2M | $5.34B | 0.3% | 1.2% | -11.3% |
| 11 | FMR LLC | 20.8M | $5.23B | 0.2% | 1.2% | -4.5% |
| 12 | NORTHERN TRUST CORP | 20.6M | $5.17B | 0.6% | 1.2% | -3.1% |
| 13 | FRANKLIN RESOURCES INC | 19.9M | $5.01B | 1.1% | 1.1% | +36.9% |
| 14 | Capital World Investors | 19.2M | $4.83B | 0.6% | 1.1% | +21.1% |
| 15 | GOLDMAN SACHS GROUP INC | 16.3M | $4.10B | 0.4% | 0.9% | +7.6% |
| 16 | Capital International Investors | 15.6M | $3.94B | 0.8% | 0.9% | +8.5% |
| 17 | PRICE T ROWE ASSOCIATES INC /MD/ | 14.7M | $3.71B | 0.4% | 0.8% | +13.4% |
| 18 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 14.3M | $3.59B | 0.7% | 0.8% | +0.7% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 12.9M | $3.25B | 0.4% | 0.7% | -0.4% |
| 20 | Bank of New York Mellon Corp | 12.9M | $3.23B | 0.5% | 0.7% | -3.2% |
| 21 | UBS Group AG | 12.8M | $3.23B | 0.4% | 0.7% | -8.6% |
| 22 | Legal & General Group Plc | 11.5M | $2.91B | 0.6% | 0.7% | -5.0% |
| 23 | AMERIPRISE FINANCIAL INC | 11.5M | $2.90B | 0.6% | 0.7% | +4.1% |
| 24 | DEUTSCHE BANK AG\ | 10.8M | $2.71B | 0.8% | 0.6% | +13.0% |
| 25 | RAYMOND JAMES FINANCIAL INC | 10.4M | $2.62B | 0.7% | 0.6% | +8.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.